Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-02-23
1995-01-31
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31155
Patent
active
053859464
ABSTRACT:
N,N-disubstituted-guanidines, e.g., of the formula ##STR1## wherein R and R' are substituted or unsubstituted hydrocarbon groups. Methods are provided for the treatment of psychosis and hypertension by administering an effective amount of an N,N'-disubstituted guanidine which, preferably, has a high affinity for the sigma receptor.
REFERENCES:
patent: 1422506 (1922-07-01), Weiss
patent: 1597233 (1926-08-01), Heuser et al.
patent: 1642180 (1927-09-01), Scott
patent: 1672431 (1928-06-01), Schotte
patent: 1756315 (1930-04-01), Ter Horst
patent: 1795738 (1931-03-01), Schotte
patent: 1850682 (1932-03-01), Meiss
patent: 1915922 (1933-06-01), Christman et al.
patent: 2145214 (1939-01-01), Jayne, Jr.
patent: 2254009 (1941-08-01), Hechenbleikner
patent: 2274476 (1942-02-01), Hechenbleikner
patent: 2362915 (1944-11-01), MacGregor
patent: 2633474 (1953-03-01), Beaver
patent: 3140231 (1964-07-01), Luskin et al.
patent: 3159676 (1964-12-01), Spickett et al.
patent: 3228975 (1966-01-01), Abraham et al.
patent: 3248426 (1966-04-01), Dvornik
patent: 3270054 (1966-08-01), Gagneux et al.
patent: 3283003 (1966-11-01), Jack et al.
patent: 3301755 (1967-01-01), Mull
patent: 3320229 (1967-05-01), Szabo et al.
patent: 3409669 (1968-11-01), Dyke
patent: 3479437 (1969-11-01), Szabo et al.
patent: 3547951 (1970-12-01), Hardie et al.
patent: 3639477 (1972-02-01), L'Ltalien
patent: 3681459 (1972-08-01), Hughes et al.
patent: 3769427 (1973-10-01), Hughes et al.
patent: 3804898 (1974-04-01), Panneman
patent: 3908013 (1975-09-01), Hughes et al.
patent: 3968243 (1976-07-01), Maxwell et al.
patent: 3976643 (1976-08-01), Diamond et al.
patent: 3976787 (1976-08-01), Hughes et al.
patent: 4007181 (1977-02-01), DuCharme et al.
patent: 4014934 (1977-03-01), Hughes et al.
patent: 4051256 (1977-09-01), Swallow
patent: 4052455 (1977-10-01), Matier et al.
patent: 4109014 (1978-08-01), Liu et al.
patent: 4130663 (1978-12-01), Matier et al.
patent: 4169154 (1979-09-01), Cohen et al.
patent: 4284642 (1981-08-01), Toldy et al.
patent: 4369325 (1983-01-01), Toldy et al.
patent: 4471137 (1984-09-01), Barton et al.
patent: 4575514 (1986-03-01), Carson
patent: 4709094 (1987-11-01), Weber et al.
patent: 4780466 (1988-10-01), Hrib et al.
patent: 4898978 (1990-02-01), Bergfeld et al.
patent: 4906779 (1990-03-01), Weber et al.
patent: 5093525 (1992-03-01), Weber et al.
patent: 5190976 (1993-03-01), Weber et al.
S. Siddiqui et al., Pakistan Journal of Scientific and Industrial Research, 30(3):163-181 (1987).
C. Chavkin et al., Advances in the Biosciences, 75:407-410 (1989).
J. Keana et al., Proc. Natl. Acad. Sci. U.S.A., 86:5631-5635 (1989).
H. Wanzlick et al., Chemische Berichte, 98(10):3170-3177 (1965).
D. Lloyd et al., Tetrahedron, 33:1379-1389 (1977).
K. Akiba et al., Bulletin of the Chem. Soc. of Japan, 47(4):935-937 (1974).
Database Rtecs, No. MF735000 (1990).
E. Maida et al., Wiener Klinische Wochenschrift, 90(1):43-48 (1978).
H. Shimizu, Chem. Abstracts, 111(2), Abstr. No. 16337m (1989).
A. Heesing et al., Chem. Abstracts, 64(11), Abstr. No. 15776h (1966).
T. Tada et al., Chem. Abstracts, 104(24), Abstr. No. 208252g (1986).
L. Kiselev et al., Chem. Abstracts, 91(21), Abstr. No. 175291b (1979).
F. Monnet et al., "Multiple Sigma and PCP Receptor Ligands: Mechanism For Neuromodulation and Protection", (1991).
A. Wilson et al., J. Nuclear. Medicine, 31(5):747, abstract No. 376 (1990).
B. Cambell et al., European Journal of Pharmacology, 205:219-233 (1991).
T. Massamiri et al., The Journal of Pharmacology and Experimental Therapeutics, 259(1):22-29 (1991).
J. T. Adams et al., Eur. J. Pharm., 142:61-71 (1987).
P. N. Bhargava et al., Chemical Abstracts, 86:598, 189787b (1977).
W. D. Bowen et al., Eur. J. Pharm., 147:153-154 (1988).
B. G. Campbell et al., J. Neurosci., 9(10):3380-3391 (1989).
I. V. Dranka et al., Russian J. Inorg. Chem., 26(3):347-350 (1981).
G. J. Durant et al., J. Med. Chem., 28:1414-1422 (1985).
S. E. File, TINS, 10:461-463 (1987).
H. W. Geluk et al., J. Med. Chem., 17:712-715 (1969).
M. P. Kavanaugh et al., Proc. Natl. Acad. Sci. USA, 85:2844-2848 (1988).
C. A. Maryanoff et al., J. Org. Chem., 51:1882-1884 (1986).
S. R. Safir et al., J. Org. Chem., 13:924-932 (1948).
M. W. Scherz et al., J. Med. Chem., 33:2421-2429 (1990).
M. S. Sonders et al., TINS, 11:37-40 (1988).
A. A. Stolyarchuk et al., Chemical Abstracts, 86:522-523, 121071h (1977).
B. Tester et al., Society for Neuroscience, 19th Annual Meeting, p. 983, 396.17 (1989).
T. J. R. Weakley et al., Acta Cryst., 46:2234-2236 (1990).
E. Weber et al., Proc. Natl. Acad. Sci. U.S.A., 83:8784-8788 (1986).
H. G. M. Westenberg et al., Psychopharmacol. Bull., 23:145-149 (1987).
Supplementary Partial European Search Report for the corresponding European Application No. EP 8790447.
International Search Report for International Application No. PCT/US90/02398, filed May 2, 1990.
Keana John
Weber Eckard
Conlin David G.
Corless Peter F.
Henley III Raymond J.
State of Oregon acting by and through the Oregon State Board of
LandOfFree
Method for treating hypertension with disubstituted granidine co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating hypertension with disubstituted granidine co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hypertension with disubstituted granidine co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102616